Adenoid basal carcinoma of the uterine cervix: Detection of integrated human papillomavirus in a rare tumor of putative 'reserve cell' origin

International Journal of Gynecological Pathology

Volumn 16, Issue 4, 1997, Pages 307-312

  Grayson, Wayne ^a   Taylor, Louise F ^a   Cooper, Kum ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

Adenoid basal carcinoma; Cervix uteri; Human papilloma virus

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; GENOTYPE; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; WART VIRUS;

EID: 0030845827     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199710000-00003     Document Type: Article

References (34)

1. Baggish MS, Woodruff JD. Adenoid-basal carcinoma of the cervix. Obstet Gynecol 1966;28:213-18.
2. Kurman RJ, Norris HJ, Wilkinson EJ. Tumors of the cervix: In: Rosai J, Sobin LH eds. Atlas of Tumour Pathology - Fascicle 4, 3rd Series: Tumors of the cervix, vagina and vulva. Washington, DC: Armed Forces Institute of Pathology, 1992:100-1.
3. Ferry JA, Scully RE. "Adenoid cystic" carcinoma and adenoid basal carcinoma of the uterine cervix: A study of 28 cases. Am J Surg Pathol 1988;12:134-44.
4. Young RH, Scully RE. Invasive adenocarcinoma and related tumours of the uterine cervix. Sem Diagn Pathol 1990;7:205-7.
5. De Villiers E-M. Heterogeneity of the human papillomavirus group. J Virol 1989;63:4898-903.
6. Zur Hausen H. Papilloma viruses in ano-genital cancer as a model to understand the role of viruses in human cancer. Cancer Res 1989;49:4677-81.
7. Chang F. Role of papillomaviruses. J Clin Pathol 1990;43:269-76.
8. McDougall JK. Human papillomavirus immortalising and transformation. Papillomavirus Report 1990;1:1-4.
9. Choo K-B, Pan C-C, Han S-H. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: Preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987;161:259-61.
10. Cooper K. The role of human papillomavirus in cervical cancer (Editorial). S Afr Med J 1995;85:841-2.
11. Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO'D. In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: Evidence for putative HPV integration in vivo. J Clin Pathol 1991;44:400-5.
12. Cooper K, Herrington CS, Graham AK, Evans MF, Mc Gee JO'D. In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa. J Clin Pathol 1991;44:406-9.
13. Cooper K, Herrington CS, Lo ES-F, Evans MF, McGee JO'D. Integration of human papillomavirus types 17 and 18 in cervical adenocarcinoma. J Clin Pathol 1992;45:382-84.
14. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus types 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992;23:117-28.
15. Gordon AN, Bornstein J, Kaufman RH, Estrada RG, Adams E, Adler-Storthz K. Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: Analysis by in situ hybridization. Gynecol Oncol 1989;35:345-8.
16. Wilcynski SP, Walker J, Liao S-Y, Bergen S, Berman M. Adenocarcinoma of the cervix associated with human papillomavirus. Cancer 1988;62:1331-6.
17. Grayson W, Taylor L, Cooper K. Detection of integrated high risk human papillomavirus in adenoid cystic carcinoma of the uterine cervix. J Clin Pathol 1996;49:805-9.
18. Young RH, Clement PB, Scully RE. Premalignant and malignant glandular lesions of the uterine cervix. In: Clement PB. Young RH, eds. Tumors and tumorlike lesions of the uterine corpus and cervix. New York: Churchill Livingstone, 1993:124-36.
19. Cooper K, Herrington CS, Strickland JE, Evans MF, McGee JO'D. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol 1991;44:990-6.
20. Baggish MS, Woodruff JD. Adenoid basal lesions of the cervix. Obstet Gynecol 1971;37:807-19.
21. Daroca PJ, Dhurandhar HN. Basaloid carcinoma of uterine cervix. Am J Surg Pathol 1980;4:235-9.
22. Van Dinh T, Woodruff JD. Adenoid cystic and adenoid basal carcinomas of the cervix. Obstet Gynecol 1985;65:705-9.
23. Prempree T, Villasanta U, Tang CK. Management of adenoid cystic carcinoma of the uterine cervix (cylindroma). Cancer 1980;46: 1631-5.
24. Moss LD, Collins DN. Squamous and adenoid cystic basal cell carcinoma of the cervix uteri. Am J Obstet Gynecol 1964;88:86-90.
25. Duggan MA, Benoit JL, McGregor SE, Nation JG, Inoue M, Stuart GC. The human papillomavirus status of 114 endocervical adenocarcinoma cases by dot blot hybridization. Hum Pathol 1993;24: 121-5.
26. Cooper K. Human papillomavirus and endocervical adenocarcinoma (Letter). Hum Pathol 1994;25:216-7.
27. Herrington CS, De Angelis M, Evans MF, Troncone G, McGee JO'D. Detection of high risk human papillomavirus in routine cervical smears: Strategy for screening. J Clin Pathol 1992;45: 385-90.
28. Schwartz E, Freese UK, Gissman L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-4.
29. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
30. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 148:76-9.
31. Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene produce. Science 1989;243:934-7.
32. Vousden KH, Wrede D, Crook T. Human papillomavirus oncoprotein function: Releasing the brakes on cell growth control. Papillomavirus Report 1991;2:1-3.
33. Shibata D, Fu YS, Gupta JW, Shah KV, Arnheim N, Martin WJ. Detection of human papillomavirus in normal and dysplastic tissue by the polymerase chain reaction. Lab Invest 1988;59:555-9.
34. Bauer HM, Greer CE, Manos MM. Determination of genital papillomavirus infection by consensus polymerase chain reaction amplification. In: Herrington CS, McGee JO'D, eds. Diagnostic molecular pathology: a practical approach (Vol II). Oxford: Oxford University Press, 1991:131-51.